Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | BCL9 | O00512 | 1/20 | 0.49 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11513733 | 0.95 | KMT2A (0.57) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL27709110 | 0.93 | KMT2A (0.59) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL16586533 | 0.93 | KMT2A (0.59) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL299704 | 0.93 | KMT2A (0.59) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL11650732 | 0.93 | KMT2A (0.59) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL5822065 | 0.91 | KMT2A (0.61) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL612295 | 0.89 | BCL9 (0.60) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL6866899 | 0.89 | KMT2A (0.61) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL6869289 | 0.89 | KMT2A (0.56) | KMT2ALMNAALDH1A1MAPTHTT | |
| Hydrochloric Acid SCHEMBL27429774 | 0.87 | BCL9 (0.58) | KMT2ALMNAALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103495340-B | The method of SOx in compound alcamines solution removal gas | BEIJING BOYUAN HENGSHENG HIGH-TECHNOLOGY CO.,LTD. (CN) | 2015-11-18 | — | — | CN | claimed |
| CN-103495340-A | Method of removing SOx in gas by compound alkanolamine solution | BEIJING BOYUAN HENGSHENG HIGH TECHNOLOGY CO LTD | 2014-01-08 | — | — | CN | claimed |
| WO-2018100137-A1 | NUCLEOSIDE TRIPHOSPHATE AND NUCLEOSIDE TRIPHOSPHATE ANALOGUE PRODRUGS | UNIVERSITÄT HAMBURG (DE) | 2018-06-07 | — | — | WO | disclosed |
| CN-103495340-B | The method of SOx in compound alcamines solution removal gas | BEIJING BOYUAN HENGSHENG HIGH-TECHNOLOGY CO.,LTD. (CN) | 2015-11-18 | — | — | CN | disclosed |
| US-9045423-B2 | Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient | KOWA COMPANY, LTD. (JP) | 2015-06-02 | — | — | US | disclosed |
| US-20140249144-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT | KOWA COMPANY, LTD. (JP) | 2014-09-04 | — | — | US | disclosed |
| US-8791090-B2 | Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient | KOWA COMPANY, LTD. (JP) | 2014-07-29 | — | — | US | disclosed |
| CN-103495340-A | Method of removing SOx in gas by compound alkanolamine solution | BEIJING BOYUAN HENGSHENG HIGH TECHNOLOGY CO LTD | 2014-01-08 | — | — | CN | disclosed |
| EP-2415764-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT | Kowa Company, Ltd. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120004197-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT | KOWA COMPANY, LTD. (JP) | 2012-01-05 | — | — | US | disclosed |
| US-20030032774-A1 | Novel opioid peptides for the treatment of pain | ASTRAZENECA AB | 2003-02-13 | — | — | US | disclosed |
| CN-1161962-A | Sulphonic-acid-amide derivative | KONO PHARMACEUTICAL IND K K (JP) | 1997-10-15 | — | — | CN | disclosed |
| US-4124579-A | FOR POLYMERIC MATERIALS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249144-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT | EPOR, HBG1, HBG2 | KMT2A 1459/4885LMNA 4334/4885ALDH1A1 1491/4885 |
| US-20030032774-A1 | Novel opioid peptides for the treatment of pain | OPRL1, OPRK1, OPRM1 | KMT2A 3723/4885LMNA 4361/4885ALDH1A1 4281/4885 |
| US-20120004197-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT | EPOR, HBG1, HBG2 | KMT2A 1459/4885LMNA 4334/4885ALDH1A1 1491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.